<i>Mycobacterium abscessus</i> pulmonary infection during hepatitis C treatment with telaprevir, peginterferon and ribavirin

dc.contributor.authorSoza, Alejandro
dc.contributor.authorLabbe, Pilar
dc.contributor.authorArrese, Marco
dc.contributor.authorRiquelme, Arnoldo
dc.contributor.authorBarrera, Francisco
dc.contributor.authorBenitez, Carlos
dc.contributor.authorHuete, Alvaro
dc.contributor.authorElvira Balcells, M.
dc.contributor.authorLabarca, Jaime
dc.date.accessioned2025-01-23T21:37:41Z
dc.date.available2025-01-23T21:37:41Z
dc.date.issued2015
dc.description.abstractThe first generation protease inhibitors has been the mainstay of hepatitis C treatment for the last couple of years, showing marked improvement in sustained virological response, but also increased side effects. Infection has emerged as a common complication of telaprevir and boceprevir in combination with peginterferon and ribavirin, usually caused by common pathogens. We present the case of a 65 years old man who developed a Mycobacterium abscessus pulmonary infection during treatment with telaprevir, peginterferon and ribavirin. The patient was successfully treated with amikacin, imipenem and chlarithro-mycin. The present case is relevant for increasing awareness for recognition of opportunistic-infections and particularly nontuberculous mycobacterial infections in patients receiving triple therapy for chronic hepatitis C, especially in cirrhotic subjects who develop significant lymphopenia.
dc.description.funderFONDECYT from the Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)
dc.fuente.origenWOS
dc.identifier.issn1665-2681
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/101580
dc.identifier.wosidWOS:000350903700016
dc.issue.numero1
dc.language.isoen
dc.pagina.final136
dc.pagina.inicio132
dc.revistaAnnals of hepatology
dc.rightsacceso restringido
dc.subjectHCV
dc.subjectBoceprevir
dc.subjectPeginterferon
dc.subjectRibavirin
dc.subjectLymphopenia
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.title<i>Mycobacterium abscessus</i> pulmonary infection during hepatitis C treatment with telaprevir, peginterferon and ribavirin
dc.typeartículo
dc.volumen14
sipa.indexWOS
sipa.trazabilidadWOS;2025-01-12
Files